s 3B Revocation or suspension of approval of medical institution in respect of approved medical treatment or services
3B.—(1) The Minister may revoke an approval granted to a medical institution in respect of any approved medical treatment or services if —(a) the approval has been obtained by the medical institution by fraud, or the medical institution has, in connection with the application for the grant of the approval, made a statement or provided any information or document that is false, misleading or inaccurate in a material particular; (b) there is a reasonable likelihood that the medical institution is contravening or not complying with, or has contravened or failed to comply with, a condition of the approval imposed under section 3A, or any provision of this Act; (c) the medical institution is, or is likely to be, declared a bankrupt (if a natural person) or has gone, or is likely to go, into compulsory or voluntary liquidation other than for the purpose of amalgamation or reconstruction; (d) the medical institution has made any assignment to, or composition with, the medical institution’s creditors or is unable to pay its debts; (e) any of the following persons has been convicted, whether in Singapore or elsewhere, of an offence involving fraud or dishonesty, or of an offence the conviction for which involves a finding that the person convicted had acted fraudulently or dishonestly, whether the applicable offence is committed before, on or after the date of commencement of section 4 of the MediShield Life Scheme (Amendment) Act 2024:(i) the medical institution; (ii) any key appointment holder, Principal Officer or Clinical Governance Officer of the medical institution; (iii) any medical practitioner employed or engaged by the medical institution to provide any approved medical treatment or services; (f) the licence granted to the medical institution under the Healthcare Services Act 2020 authorising the medical institution to provide the licensable healthcare service that the approved medical treatment or services is or is a part of, is revoked or suspended; (g) all of the following conditions are satisfied:(i) the medical institution was approved under section 3A in respect of that approved medical treatment or services on the condition that the approved medical treatment or services is provided by certain authorised service delivery modes (as defined in section 3A(5)(a)); (ii) in respect of the licensable healthcare service that the approved medical treatment or services is or is a part of, the medical institution ceases to be approved under the Healthcare Services Act 2020 to provide the licensable healthcare service by every one of those authorised service delivery modes; (h) the Minister considers it in the public interest to do so; or (i) any other ground that is prescribed by the Minister is satisfied. (2) The Minister may, if the Minister considers it desirable to do so —(a) suspend the approval of a medical institution in respect of any approved medical treatment or services for a specified period, instead of revoking the approval under subsection (1); and (b) at any time —(i) extend the suspension for a specified period; or (ii) cancel the suspension. (3) The Minister must not revoke an approval under subsection (1), or suspend an approval under subsection (2), without giving the medical institution concerned written notice of the Minister’s intention to do so and a reasonable opportunity to make representations as to why the approval should not be revoked or suspended. (4) Subsection (3) does not apply where the medical institution —(a) if a natural person — has died or is adjudged bankrupt; or (b) in any other case — has been dissolved or wound up or has otherwise ceased to exist. (5) Where any approval of a medical institution for an approved medical treatment or services is revoked or suspended —(a) the approved medical treatment or services is not a claimable medical treatment or services in relation to that medical institution where it is provided during the period of suspension or on or after the date of revocation, unless the Minister otherwise permits; but (b) the revocation or suspension does not affect any claim for any such approved medical treatment or services provided before or after the period of suspension, or before the date of revocation. (6) Where the Minister revokes or suspends any approval of a medical institution in respect of any approved medical treatment or services under this section, the medical institution must immediately inform all the patients and customers that are or may be provided the licensable healthcare service that the approved medical treatment or services is or is a part of, of the revocation or suspension. (7) For the purposes of this section —(a) a medical institution that is a company is unable to pay its debts if it is deemed to be unable to pay its debts under section 125(2) of the Insolvency, Restructuring and Dissolution Act 2018; (b) a medical institution that is an unregistered company is unable to pay its debts if it is deemed to be unable to pay its debts under section 246(2) of the Insolvency, Restructuring and Dissolution Act 2018; and (c) a medical institution that is a limited liability partnership is unable to pay its debts if it is deemed to be unable to pay its debts under paragraph 3(2) of the Fifth Schedule to the Limited Liability Partnerships Act 2005. (8) In this section —“Clinical Governance Officer”, “key appointment holder” and “Principal Officer” have the meanings given by section 2(1) of the Healthcare Services Act 2020; “company” has the meaning given by section 4(1) of the Companies Act 1967; “limited liability partnership” has the meaning given by section 4(1) of the Limited Liability Partnerships Act 2005; “unregistered company” has the meaning given by section 245 of the Insolvency, Restructuring and Dissolution Act 2018. [Act 40 of 2024 wef 01/04/2025] —(1) The Minister may revoke an approval granted to a medical institution in respect of any approved medical treatment or services if —(a) the approval has been obtained by the medical institution by fraud, or the medical institution has, in connection with the application for the grant of the approval, made a statement or provided any information or document that is false, misleading or inaccurate in a material particular; (b) there is a reasonable likelihood that the medical institution is contravening or not complying with, or has contravened or failed to comply with, a condition of the approval imposed under section 3A, or any provision of this Act; (c) the medical institution is, or is likely to be, declared a bankrupt (if a natural person) or has gone, or is likely to go, into compulsory or voluntary liquidation other than for the purpose of amalgamation or reconstruction; (d) the medical institution has made any assignment to, or composition with, the medical institution’s creditors or is unable to pay its debts; (e) any of the following persons has been convicted, whether in Singapore or elsewhere, of an offence involving fraud or dishonesty, or of an offence the conviction for which involves a finding that the person convicted had acted fraudulently or dishonestly, whether the applicable offence is committed before, on or after the date of commencement of section 4 of the MediShield Life Scheme (Amendment) Act 2024:(i) the medical institution; (ii) any key appointment holder, Principal Officer or Clinical Governance Officer of the medical institution; (iii) any medical practitioner employed or engaged by the medical institution to provide any approved medical treatment or services; (f) the licence granted to the medical institution under the Healthcare Services Act 2020 authorising the medical institution to provide the licensable healthcare service that the approved medical treatment or services is or is a part of, is revoked or suspended; (g) all of the following conditions are satisfied:(i) the medical institution was approved under section 3A in respect of that approved medical treatment or services on the condition that the approved medical treatment or services is provided by certain authorised service delivery modes (as defined in section 3A(5)(a)); (ii) in respect of the licensable healthcare service that the approved medical treatment or services is or is a part of, the medical institution ceases to be approved under the Healthcare Services Act 2020 to provide the licensable healthcare service by every one of those authorised service delivery modes; (h) the Minister considers it in the public interest to do so; or (i) any other ground that is prescribed by the Minister is satisfied. (2) The Minister may, if the Minister considers it desirable to do so —(a) suspend the approval of a medical institution in respect of any approved medical treatment or services for a specified period, instead of revoking the approval under subsection (1); and (b) at any time —(i) extend the suspension for a specified period; or (ii) cancel the suspension. (3) The Minister must not revoke an approval under subsection (1), or suspend an approval under subsection (2), without giving the medical institution concerned written notice of the Minister’s intention to do so and a reasonable opportunity to make representations as to why the approval should not be revoked or suspended. (4) Subsection (3) does not apply where the medical institution —(a) if a natural person — has died or is adjudged bankrupt; or (b) in any other case — has been dissolved or wound up or has otherwise ceased to exist. (5) Where any approval of a medical institution for an approved medical treatment or services is revoked or suspended —(a) the approved medical treatment or services is not a claimable medical treatment or services in relation to that medical institution where it is provided during the period of suspension or on or after the date of revocation, unless the Minister otherwise permits; but (b) the revocation or suspension does not affect any claim for any such approved medical treatment or services provided before or after the period of suspension, or before the date of revocation. (6) Where the Minister revokes or suspends any approval of a medical institution in respect of any approved medical treatment or services under this section, the medical institution must immediately inform all the patients and customers that are or may be provided the licensable healthcare service that the approved medical treatment or services is or is a part of, of the revocation or suspension. (7) For the purposes of this section —(a) a medical institution that is a company is unable to pay its debts if it is deemed to be unable to pay its debts under section 125(2) of the Insolvency, Restructuring and Dissolution Act 2018; (b) a medical institution that is an unregistered company is unable to pay its debts if it is deemed to be unable to pay its debts under section 246(2) of the Insolvency, Restructuring and Dissolution Act 2018; and (c) a medical institution that is a limited liability partnership is unable to pay its debts if it is deemed to be unable to pay its debts under paragraph 3(2) of the Fifth Schedule to the Limited Liability Partnerships Act 2005. (8) In this section —“Clinical Governance Officer”, “key appointment holder” and “Principal Officer” have the meanings given by section 2(1) of the Healthcare Services Act 2020; “company” has the meaning given by section 4(1) of the Companies Act 1967; “limited liability partnership” has the meaning given by section 4(1) of the Limited Liability Partnerships Act 2005; “unregistered company” has the meaning given by section 245 of the Insolvency, Restructuring and Dissolution Act 2018.